Liberator Medical Holdings Inc (LBMH) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
2979 SE GRAN PARK WAY STUART, FL 34997 |
| State of Incorp. | NV |
| Fiscal Year End | September 30 |
| Industry (SIC) | 5912 - Drug Stores and Proprietary Stores (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 9/30/2015 | 9/30/2014 | 9/30/2013 | |||
|---|---|---|---|---|---|
| ASSETS | |||||
| Current Assets | |||||
| Cash, cash equivalents, and short-term investments | 12,261 | 12 | |||
| Cash and cash equivalents | 12,261 | 12 | |||
| Receivables | 8,866 | 8 | |||
| Inventory, net of allowances, customer advances and progress billings | 1,954 | 2 | |||
| Inventory | 1,954 | 2 | |||
| Prepaid expense and other current assets | ✕ | ✕ | 0 | ||
| Deferred tax assets | 2 | ||||
| Other undisclosed current assets | 2,454 | ||||
| Total current assets: | 25,535 | 25 | |||
| Noncurrent Assets | |||||
| Property, plant and equipment | 1,260 | 1 | |||
| Intangible assets, net (including goodwill) | 420 | 0 | |||
| Intangible assets, net (excluding goodwill) | 420 | 0 | |||
| Deferred costs | 26,936 | ||||
| Prepaid expense and other noncurrent assets | ✕ | ✕ | 0 | ||
| Deferred tax assets, net | |||||
| Other undisclosed noncurrent assets | 178 | 23 | |||
| Total noncurrent assets: | 28,794 | 24 | |||
| TOTAL ASSETS: | 54,329 | 49 | |||
| LIABILITIES AND EQUITY | |||||
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,749 | 7 | |||
| Interest and dividends payable | 1,728 | ||||
| Taxes payable | 178 | 1 | |||
| Accounts payable | 6,085 | 5 | |||
| Accrued liabilities | 1,758 | 1 | |||
| Debt | 1,500 | 2 | |||
| Other liabilities | 161 | 0 | |||
| Deferred tax liabilities | 9 | ||||
| Other undisclosed current liabilities | (1,500) | (8) | |||
| Total current liabilities: | 9,910 | 9 | |||
| Noncurrent Liabilities | |||||
| Liabilities, other than long-term debt | (9,938) | (9) | |||
| Deferred tax liabilities, net | (10,391) | (9) | |||
| Other liabilities | 453 | 0 | |||
| Other undisclosed noncurrent liabilities | 21,922 | 19 | |||
| Total noncurrent liabilities: | 11,984 | 10 | |||
| Total liabilities: | 21,894 | 19 | |||
| Equity | |||||
| Equity, attributable to parent, including: | 32,435 | 30 | |||
| Common stock | 54 | 0 | |||
| Treasury stock, value | 480 | 0 | |||
| Additional paid in capital | 36,385 | 35 | |||
| Accumulated deficit | (3,524) | (5) | |||
| Other undisclosed equity, attributable to parent | (960) | (1) | |||
| Total equity: | 32,435 | 30 | |||
| TOTAL LIABILITIES AND EQUITY: | 54,329 | 49 | |||
Income Statement (P&L) ($ in thousands)
| 9/30/2015 | 9/30/2014 | 9/30/2013 | ||
|---|---|---|---|---|
| Revenues (Revenue, Net) | 74,569 | 69 | ||
| Cost of revenue (Cost of Goods and Services Sold) | (27,822) | (26) | ||
| Other undisclosed gross profit | 14 | |||
| Gross profit: | 46,761 | 43 | ||
| Operating expenses | (34,052) | (32) | ||
| Other operating income, net (Other Expenses) | 50 | |||
| Other undisclosed operating loss | (50) | |||
| Operating income: | 12,709 | 12 | ||
| Nonoperating expense | (0) | |||
| Investment income, nonoperating | (0) | |||
| Other nonoperating income | 0 | |||
| Interest and debt expense | 50 | 0 | ||
| Income from continuing operations before equity method investments, income taxes: | 12,759 | 12 | ||
| Other undisclosed income (loss) from continuing operations before income taxes | (100) | 0 | ||
| Income from continuing operations before income taxes: | 12,659 | 12 | ||
| Income tax expense | (4,857) | (5) | ||
| Income from continuing operations: | 7,802 | 7 | ||
| Income before gain (loss) on sale of properties: | 7,802 | 7 | ||
| Net income available to common stockholders, diluted: | 7,802 | 7 | ||
Comprehensive Income ($ in thousands)
| 9/30/2015 | 9/30/2014 | 9/30/2013 | ||
|---|---|---|---|---|
| Net income: | 7,802 | 7 | ||
| Comprehensive income, net of tax, attributable to parent: | 7,802 | 7 | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.